| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad2cfffd86f554784dd0c1eaee23fe62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b936f92017d116e0a74c90c71e1c6384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ec61ca578275fa046b99271f8b7cd91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0be0cea04782f3ef10e1c4fc0e4030
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ef7b019e1a0eeea2a09b8f78a2cc1df |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b0df6d92c391ce596962d037fb1ecf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fdd00f3b7fbb05e6d1b3f7f15ecdcc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71889755f6194ab4d248576dfc7ed725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac001f827ecd0ba0485a5eb9110d6c26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02199a022a014f1d26a42dcccd3c501f |
| publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008260732-A1 |
| titleOfInvention |
Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis |
| abstract |
The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8840887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8350010-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9011326-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284376-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013204092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009098112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009220504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7973138-B2 |
| priorityDate |
2002-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |